BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

89 related articles for article (PubMed ID: 7659181)

  • 1. Glutathione S-transferase isoenzymes and glutathione in renal cell carcinoma and kidney tissue.
    Gajewska J; Szczypka M; Pych K; Borówka A; Laskowska-Klita T
    Neoplasma; 1995; 42(4):167-72. PubMed ID: 7659181
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Glutathione S-transferase isoenzyme profile in non-tumor and tumor human kidney tissue.
    Simić T; Mimić-Oka J; Ille K; Dragicević D; Savić-Radojević A
    World J Urol; 2003 May; 20(6):385-91. PubMed ID: 12811499
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Altered antioxidant capacity in human renal cell carcinoma: role of glutathione associated enzymes.
    Pljesa-Ercegovac M; Mimic-Oka J; Dragicevic D; Savic-Radojevic A; Opacic M; Pljesa S; Radosavljevic R; Simic T
    Urol Oncol; 2008; 26(2):175-81. PubMed ID: 18312938
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Image analysis of proliferating cell nuclear antigen expression and immunohistochemical profiles in renal cell carcinoma associated with acquired cystic kidney disease: comparison with classic renal cell carcinoma.
    Khurana KK; Truong LD; Verani RR
    Mod Pathol; 1998 Apr; 11(4):339-46. PubMed ID: 9578084
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Renal papillary adenoma--a putative precursor of papillary renal cell carcinoma.
    Wang KL; Weinrach DM; Luan C; Han M; Lin F; Teh BT; Yang XJ
    Hum Pathol; 2007 Feb; 38(2):239-46. PubMed ID: 17056094
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Differential expression of the enzyme that esterifies retinol, lecithin:retinol acyltransferase, in subtypes of human renal cancer and normal kidney.
    Zhan HC; Gudas LJ; Bok D; Rando R; Nanus DM; Tickoo SK
    Clin Cancer Res; 2003 Oct; 9(13):4897-905. PubMed ID: 14581364
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Glutathione S-transferase expression in renal cell carcinoma: a new marker of differentiation.
    Grignon DJ; Abdel-Malak M; Mertens WC; Sakr WA; Shepherd RR
    Mod Pathol; 1994 Feb; 7(2):186-9. PubMed ID: 8008741
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Glutathione and glutathione metabolizing enzymes in tissues and blood of breast cancer patients.
    Gromadzińska J; Wasowicz W; Andrijewski M; Skłodowska M; Quispe OZ; Wołkanin P; Ołborski B; Płuzańska A
    Neoplasma; 1997; 44(1):45-51. PubMed ID: 9201280
    [TBL] [Abstract][Full Text] [Related]  

  • 9. FHIT expression in clear cell renal carcinomas: versatility of protein levels and correlation with survival.
    Ramp U; Caliskan E; Ebert T; Karagiannidis C; Willers R; Gabbert HE; Gerharz CD
    J Pathol; 2002 Apr; 196(4):430-6. PubMed ID: 11920739
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Overexpression of glutathione s-transferase alpha in clear cell renal cell carcinoma.
    Chuang ST; Chu P; Sugimura J; Tretiakova MS; Papavero V; Wang K; Tan MH; Lin F; Teh BT; Yang XJ
    Am J Clin Pathol; 2005 Mar; 123(3):421-9. PubMed ID: 15716239
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Glutathione S-transferase activity as an early marker for malignant tumors of corpus uteri.
    Osmak M; Babić D; Abramić M; Ambriović A; Milicić D; Eljuga D; Vuković L
    Neoplasma; 1997; 44(5):324-8. PubMed ID: 9473794
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Glutathione-associated enzymes in the human cell lines of the National Cancer Institute Drug Screening Program.
    Tew KD; Monks A; Barone L; Rosser D; Akerman G; Montali JA; Wheatley JB; Schmidt DE
    Mol Pharmacol; 1996 Jul; 50(1):149-59. PubMed ID: 8700107
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Glutathione and GSH-dependent enzymes in patients with liver cirrhosis and hepatocellular carcinoma.
    Czeczot H; Scibior D; Skrzycki M; Podsiad M
    Acta Biochim Pol; 2006; 53(1):237-42. PubMed ID: 16404476
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Renal tubulocystic carcinoma is closely related to papillary renal cell carcinoma: implications for pathologic classification.
    Zhou M; Yang XJ; Lopez JI; Shah RB; Hes O; Shen SS; Li R; Yang Y; Lin F; Elson P; Sercia L; Magi-Galluzzi C; Tubbs R
    Am J Surg Pathol; 2009 Dec; 33(12):1840-9. PubMed ID: 19898225
    [TBL] [Abstract][Full Text] [Related]  

  • 15. C-kit expression in renal oncocytomas and chromophobe renal cell carcinomas.
    Huo L; Sugimura J; Tretiakova MS; Patton KT; Gupta R; Popov B; Laskin WB; Yeldandi A; Teh BT; Yang XJ
    Hum Pathol; 2005 Mar; 36(3):262-8. PubMed ID: 15791570
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Expression of GLUT1 in primary renal tumors: morphologic and biologic implications.
    Ozcan A; Shen SS; Zhai QJ; Truong LD
    Am J Clin Pathol; 2007 Aug; 128(2):245-54. PubMed ID: 17638658
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Glutathione conjugation of trichloroethylene in rats and mice: sex-, species-, and tissue-dependent differences.
    Lash LH; Qian W; Putt DA; Jacobs K; Elfarra AA; Krause RJ; Parker JC
    Drug Metab Dispos; 1998 Jan; 26(1):12-9. PubMed ID: 9443846
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Expression of heparanase in renal cell carcinomas: implications for tumor invasion and prognosis.
    Mikami S; Oya M; Shimoda M; Mizuno R; Ishida M; Kosaka T; Mukai M; Nakajima M; Okada Y
    Clin Cancer Res; 2008 Oct; 14(19):6055-61. PubMed ID: 18809970
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Analysis of the expression of HLA class I, proinflammatory cytokines and chemokines in primary tumors from patients with localized and metastatic renal cell carcinoma.
    Romero JM; Aptsiauri N; Vazquez F; Cozar JM; Canton J; Cabrera T; Tallada M; Garrido F; Ruiz-Cabello F
    Tissue Antigens; 2006 Oct; 68(4):303-10. PubMed ID: 17026465
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Impairment of glutathione biosynthetic pathway in uraemia and dialysis.
    Alhamdani MS
    Nephrol Dial Transplant; 2005 Jan; 20(1):124-8. PubMed ID: 15632350
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.